Meeting Coverage


American Association for the Study of Liver Diseases

Will Fresh Look at Obeticholic Acid Data in NASH Sway FDA?

Latest REGENERATE analysis comes on heels of REVERSE flop

AASLD in text over an image of the Washington Convention Center.

Latest AASLD Meeting Coverage

Steroids and G-CSF Boost 90-Day Survival in Severe Alcoholic Hepatitis

Plus: Normothermic machine perfusion for liver transplants and Noom Weight for NASH

November 11, 2022
Novel Hepatitis B Drug Hints at Long-Term 'Functional Cure' for Some in Early Trial

With 10% efficacy at 6 months post-treatment, a finite HBV treatment may be on the horizon

November 10, 2022
Efruxifermin Led to NASH Resolution, Fibrosis Improvement in Mid-Stage Trial

Both 50- and 28-mg doses improved fibrosis vs placebo, without worsening of NASH

November 10, 2022
Maralixibat Takes Out the Itch of Rare Liver Disease

Ileal bile acid transporter inhibitor could become second drug for PFIC

November 9, 2022
Odevixibat Shows 'Encouraging Results' for Kids With Alagille Syndrome

Significant improvements in itching, bile acid levels for rare, life-threatening liver disorder

November 9, 2022
Acamprosate Appears Safe for People With AUD and Liver Disease

Phase II data suggest drug is well-tolerated and can reduce cravings in this group of patients

November 9, 2022
Tenofovir, Vaccine Combo Eliminates Mom-to-Child HBV Transmission

100% success rate even without the use of hepatitis B immunoglobulin

November 7, 2022
BP Control Beneficial for Liver Transplant Recipients

Patients who kept their blood pressure under 140/90 mm Hg had better kidney function at 1 year

November 7, 2022
Earlier Terlipressin May Be Better for HRS-AKI in Acute-on-Chronic Liver Failure

More acute kidney injury reversals at 7 days and lower mortality with initiation at 12 hours

November 7, 2022
Low Carb Diet Boosts Weight Loss for Liver Transplant Recipients With Obesity

LCD also positively impacted patients' metabophenotype

November 6, 2022
Pandemic's Impact on Liver Disease in the Spotlight at Liver Meeting

A roundup of news from the AASLD annual meeting

November 4, 2022
Is Weight Protective for NAFLD Patients Undergoing Transplant?

UNOS data showed differences in waitlist removal, all-cause mortality based on obesity status

November 18, 2021
Hepatology Not Immune to Workplace Discrimination

Women, racial/ethnic minorities most likely to experience discriminatory behavior

November 17, 2021
Need for Liver Transplants Rising Sharply in Seniors

Post-transplant mortality still higher versus younger patients, but improving over time

November 17, 2021